Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10980804 Methods of treating cholangiocarcinoma

Patent 10980804 was granted and assigned to Foundation Medicine on April, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Foundation Medicine

Current Assignee

Foundation Medicine

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10980804

Date of Patent

April 20, 2021

Patent Application Number

14761518

Date Filed

January 17, 2014

Patent Citations

‌

US Patent 10000814 ALK and NTRK1 fusion molecules and uses thereof

Patent Citations Received

‌

US Patent 11771698 Methods of treating cholangiocarcinoma

‌

US Patent 11578372 NTRK1 fusion molecules and uses thereof

Patent Primary Examiner

‌

Raymond J. Henley, III

Patent abstract

Methods and compositions for treating cholangiocarcinoma.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10980804 Methods of treating cholangiocarcinoma

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API